| 30-day Mortality (N= 104 with 16 deaths) |
| Variable |
HR (CI)* |
P Value |
| APACHE II |
1.10 (1.01-1.22) |
0.04** |
| Age, years |
1.01 (0.97-1.05) |
0.72 |
| Male |
0.60 (0.18-2.00) |
0.21 |
| Thoracenteses performed |
0.51 (0.06-4.04) |
0.52 |
| Admission Reason: |
|
|
| Pulmonary disease |
2.55 (0.65-10.05) |
0.18 |
| Malignancy |
6.94 (1.61-29.86) |
0.01** |
| Kidney disease |
1.41 (0.15-12.89) |
0.76 |
| 12 month Mortality (N = 104 with 33 deaths) |
| APACHE II |
1.11 (1.03-1.19) |
0.01** |
| Age, years |
1.04 (1.01-1.07) |
0.03** |
| Male |
0.79 (0.38-1.66) |
0.54 |
| Thoracenteses performed |
1.34 (0.45-3.96) |
0.60 |
| Admission Reason: |
|
|
| Pulmonary disease |
2.45 (1.06-5.64) |
0.04** |
| Malignancy |
5.27 (1.82-15.31) |
0.01** |
| Kidney disease |
0.89 (0.20-4.06) |
0.88 |
HR-hazard ratio; CI- 95% confidence interval; APACHE-Acute
Physiology and Chronic Health Evaluation;
* HR and CI calculated from Cox Proportional Hazards Model
** Statistical significance defined as a p-value < 0.05. |
